期刊文献+

含软骨基质型肉瘤的MR钆喷替酸葡甲胺增强和扩散加权成像特点 被引量:2

Characterization of chondroid matrix-forming sarcomas: gadolinium-enhanced and diffusion weighted MR imaging
原文传递
导出
摘要 目的 评价含软骨基质型肉瘤的MR Gd-DTPA增强和DWI特点.方法 在1.5 T MR机上对14例含软骨基质型肉瘤(10例软骨肉瘤和4例成软骨型骨肉瘤)和13例其他类型骨肉瘤行MR Gd-DTPA增强和DWI.DWI采用单次激发平面回波成像(SS-EPI)序列,b值分别取0、700 s/mm^2,在GE Functool后处理软件上测定肿瘤的ADC值.评价肿瘤的MRI对比强化特点,并比较ADC值差异.含软骨基质型肉瘤与其他类型骨肉瘤的ADC值两组间比较采用独立样本t检验;软骨肉瘤与成软骨型骨肉瘤的ADC值两组间采用秩和检验.结果 在14例含软骨基质型肉瘤中,间隔结节状强化者有12例,边缘强化有14例.13例其他类型骨肉瘤均表现为不均匀强化.含软骨基质型肉瘤的平均ADC值[(2.56±0.35)×10^-3mm^2/s]高于其他类型骨肉瘤的平均ADC值[(1.16±0.20)×10^-3 mm^2/s](t=12.704,P〈0.01);软骨肉瘤的ADC值与成软骨型骨肉瘤的ADC值的差异无统计学意义(Z=0.507,P=0.959).结论 Gd-DTPA增强MRI和DWI对区别含软骨基质型肉瘤与其他类型骨肉瘤有一定价值. Objective To study the Gadolinium-enhanced MRI and diffusion weighted imaging (DWI) characteristics of the chondroid matrix-forming sarcomas.Methods Contrast-enhanced MRI and DWI were performed in 14 eases of chondroid matrix-forming sarcomas (10 chondrosarcomas,4 chondroblastic esteosarcomas) and 13 cases of other types of osteosarcomas.DWI was obtained with a single-shot echo-planar imaging (EPI) sequence using a 1.5 T MR imager with two different b values of 0 and 700 s/mm2.The apparent diffusion coefficient (ADC) values were obtained in GE Functiontool software.The contrast-enhancement pattern was evaluated and the ADC values of ehondroid matrix-forming sarcomas was compared with that of other types of asteosarcoma.Independent sample t-test was performed to evaluate the difference of ADC values between the group of chondroid matrix-forming sarcoma and the group of other types of osteosarcoma.In addition, nonparametrie test was used to assess the difference of ADC values between the chondrosareoma and the chondroblastic osteosarcoma.P value less than 0.05 was considered to represent a statistical significance.Results For 14 eases of ehondroid matrix-forming sarcomas, peripheral enhancement was found in all cases, septonodular enhancement was identified in 12 cases.While 13 eases of other types of osteosarcowas demonstrated heterogeneous enhancement.The mean ADC value of chondroid matrix-forming sarcomas [(2.56 ±0.35) × 10 ^-3 mm^2/s] was significantly higher than that of other types of osteosarcoma [( 1.16±0.20) × 10^-3 mm^2/s] (t = 12.704,P 〈0.O1 ).There was no significant difference in the ADC value between the chondrosarcoma and the chondroblastie osteesarcama(Z =0.507 ,P =0.959).Conclusion Contrast-enhanced MRI and DWI can improve differentiation between chondroid matrix-forming sarcomas and other types of osteosarcomas.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2010年第6期635-638,共4页 Chinese Journal of Radiology
关键词 软骨肉瘤 骨肉瘤 磁共振成像 磁共振成像 弥散 Chondrosarcoma Osteesareoma Magnetic resonance imaging Diffusion magnetic resonance imaging
  • 相关文献

参考文献12

  • 1Dorfman HD,Czemiak B.Bone cancers.Cancer,1995,75:203-210.
  • 2Oeimaerdt MJ,Bloem JL,Eulderink F,et al.Cartilaginous tumors:correlation of gadolinium-enhanced MR imaging and histopathologic findings.Radiology,1993,186:813 -817.
  • 3Van Rijswijk CS,Kunz P,Hogendoom PC,et al.Diffusionweighted MRI in the characterization of soft-tissue tumors.J Magn Resort Imaging,2002,15:302-307.
  • 4Tang G,Liu Y,Li W,et al.Optimization ofb value in diffusionweighted MRI for the differential diagnosis of benign and malignant vertebral fractures.Skeletal Radiol,2007,36:1035-1041.
  • 5Hayashida Y,Hirai T,Yakushiji T,et al.Evaluation of diffusion-weighted imaging for the differential diagnosis of poorly contrast-enhanced and T2-prolonged bone masses:initial experience.J Magn Beson Imaging,2006,23:377-382.
  • 6Fletcler CD,Unni KK,Mertens F.软组织与骨肿瘤病理学和遗传学.北京:人民卫生出版社,2006:290-296,311-320.
  • 7Geirnaerdt MJ,Bioem JL,van der Woude HK,et al.Chondroblastic osteosarcoma:characterization by gadoliniumenhanced MR imaging correlated with histopathology.Skeletal Radiol,1998,27:145-153.
  • 8Mankin HI,Cantley KP,Lippiello L,et al.The biology of human chondrosarcoma.L Description of the cases,grading,and biochemical analyses.J Bone Joint Surg Am,1980,62:160-176.
  • 9Aoki J,Sone S,Fujioka F,et al.MR of enchondroma and chondrosarcoma:rings and arcs of Gd-DTPA enhancement.J Comput Assist Tomogr,1991,15:1011-1016.
  • 10孙燕萍,李四君,郭卫,蒋全胜,刘涛.软骨母细胞型骨肉瘤的MRI增强形式与组织病理学的相关性研究[J].中国医学影像技术,2005,21(2):301-303. 被引量:4

二级参考文献10

  • 1Mirra JM. Bone tumors:clinical, radiologic and pathologic correlations[M]. 2nd ed. Philadelphia: Lea & Febiger, 1989. 248-344,440-589.
  • 2Geirnaerdt MJA, Bloem JL, van der Woude HJ, et al. Chrondroblastic osteosarcoma: characterisation by gadolinium-enhanced MR imaging correlated with histopathology[J]. Skeletal Radiol, 1998,27(3): 145-153.
  • 3Dorfman HD, Czerniak B. Bone cancers [J]. Cancer, 1995, 75 (1Suppl) :203-210.
  • 4Unni KK. Dahlin's bone tumors:general aspects and data on 11087cases[M]. 5th ed. Springfield: C Thomas, 1996.
  • 5Huvos AG. Bone tumours. Diagnosis, treatment and prognosis [M]. 2nd ed. Philadelphia: WB Saunders,1991.
  • 6Mulder JD, Kroon HM, Schütte HE, et al. Radiologic atlas of bone tumors[M]. Amsterdam: Elsevier, 1993.
  • 7De Beuckeleer LH, De Schepper AM, Ramon F, et al. Magnetic resonance imaging of cartilaginous tumours:is it useful or necessary[J] ? Skeletal Radiol, 1996,25(2) :137-141.
  • 8Geirnaerdt MJA, Bloem JL, Eulderink F, et al. Cartilaginous tumours: correlation of gadolinium-enhanced MR imaging and histopathologic findings[J] . Radiology, 1993,186 (3): 813-817.
  • 9Aoki J, Sone S, Fujioka F, et al. MR of enchondroma and chondrosarcoma: rings and arcs of Gd-DTPA enhancement [J]. J Comput Assist Tomogr, 1991,15(6): 1011-1016.
  • 10De Beuckeleer LH, De Schepper AM, Ramon F, et al. Magnetic resonance imaging of cartilaginous tumors: a retrospective study of 79 patients[J]. Eur J Radiol, 1995,21(1) :34-40.

共引文献3

同被引文献9

  • 1孟悛非,马玲,陈应明,江波.EPI-DWI-ADC图对确定恶性骨肿瘤髓内浸润范围的价值[J].中国CT和MRI杂志,2003,1(1):46-51. 被引量:5
  • 2马玲,孟悛非,陈应明,江波.表观扩散系数值在原发性恶性骨肿瘤诊断中的价值[J].中华放射学杂志,2004,38(11):1129-1134. 被引量:20
  • 3Bielack S,Carrle D,Casali PG.Osteosarcoma:ESMO clinical rec-ommendations for diagnosis,treatment and follow-up[J].Ann On-col,2009,20(Suppl 4):S137-S139.
  • 4Provisor AJ,Ettinger LJ,Nachman JB,et al.Treatment of non-metastatic osteosarcoma of the extremity with preoperative andpostoperative chemotherapy:a report from the Children′s CancerGroup[J].J Clin Oncol,1997,15(1):76-84.
  • 5Bramer JA,van Linge JH,Grimer RJ,et al.Prognostic factors inlocalized extremity osteosarcoma:a systematic review[J].Eur JSurg Oncol,2009,35(10):1030-1036.
  • 6Rosen G,Caparros B,Huvos AG,et al.Preoperative chemothera-py for osteogenic sarcoma:selection of postoperative adjuvantchemotherapy based on the response of the primary tumor to pre-operative chemotherapy[J].Cancer,1982,49(6):1221-1230.
  • 7Hayashida Y,Yakushiji T,Awai K,et al.Monitoring therapeuticresponses of primary bone tumors by diffusion-weighted image:in-itial results[J].Eur Radiol,2006,16(12):2637-2643.
  • 8Uhl M,Saueressig U,Koehler G,et al.Evaluation of tumour nec-rosis during chemotherapy with diffusion-weighted MR imaging:preliminary results in osteosarcomas[J].Pediatr Radiol,2006,36(12):1306-1311.
  • 9马婉玲,徐俊卿,葛雅丽,韩月东,印弘,魏光全,刘莹,常英娟,赵海涛,宦怡.骨肉瘤的MRI及DWI表现[J].实用放射学杂志,2008,24(4):516-518. 被引量:6

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部